What the words on a pathology report mean, and how they shape what comes next.
Print it and bring it. Write on it — the margins are wide on purpose. The questions on the last pages are the part clinicians tell us patients most often forget to ask, so tick the ones you want answered before you go in.
This page is first because it matters most. If any of these is happening, contact your care team, an urgent care line, or emergency services — do not wait for a scheduled appointment.
Start with the report vocabulary — type, grade, markers — because everything else in your care follows from it.
Learn what a glioma is, the main types and grades, how molecular markers shape diagnosis, and what to do after hearing the word "glioma."
Understand neurons, glial cells, and how the brain is organized — the biology behind where gliomas start and why location matters.
A plain-language map of the main glioma types and how doctors now sort them by cell type, grade, and molecular markers.
What glioma grade means, the difference between low-grade and high-grade tumors, and why grade alone doesn't tell the whole story.
Why your glioma diagnosis now includes genetic details, what changed in the 2021 WHO classification, and what it means for you.
IDH status is one of the most important facts about a glioma. Learn what IDH-mutant and IDH-wildtype mean for prognosis and treatment.
Eighteen of the 265 terms in the full dictionary — the ones most likely to appear on a report or be said in a consultation.
Tick what you want answered. Appointments move fast — a written list is the difference between leaving with answers and leaving with new worries.
Independent organisations that support people with this condition. AURORA is not affiliated with any of them and does not receive anything for listing them.
Directory pending verification. Contact details and scope are being confirmed with each organisation before this booklet is published. Names are listed without links until that is done.
Research funding, trial navigation and patient support programmes.
UK information, support line and clinical trial signposting.
Condition education, care navigation and support communities.
Brain tumour trial database and copay assistance programmes.
This booklet is patient education. It describes groups of people, not you. It cannot examine you, read your scan, or know your history — and reading it creates no clinician–patient relationship. Every decision about your care belongs to you and a qualified clinician who knows your case.